scispace - formally typeset
M

Michele A. Cleary

Researcher at Merck & Co.

Publications -  58
Citations -  11625

Michele A. Cleary is an academic researcher from Merck & Co.. The author has contributed to research in topics: Gene silencing & microRNA. The author has an hindex of 36, co-authored 58 publications receiving 11107 citations. Previous affiliations of Michele A. Cleary include Stony Brook University & Cold Spring Harbor Laboratory.

Papers
More filters
Journal ArticleDOI

A microRNA component of the p53 tumour suppressor network

TL;DR: A family of miRNAs, miR-34a–c, whose expression reflected p53 status is described, whose encoded genes are direct transcriptional targets of p53, whose induction by DNA damage and oncogenic stress depends on p53 both in vitro and in vivo.
Journal ArticleDOI

Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

TL;DR: In all cases, off-target transcript silencing was accompanied by loss of the corresponding protein and occurred with dependence on siRNA concentration similar to that of silencing of the target transcript.
Journal ArticleDOI

A resource for large-scale RNA-interference-based screens in mammals

TL;DR: The construction and application of a shRNA expression library targeting 9,610 human and 5,563 mouse genes is reported, which suggests that the large-scale RNAi library can be used in specific, genetic applications in mammals, and will become a valuable resource for gene analysis and discovery.
Journal ArticleDOI

Second-generation shRNA libraries covering the mouse and human genomes.

TL;DR: Large-scale-arrayed, sequence-verified libraries comprising more than 140,000 second-generation short hairpin RNA expression plasmids, covering a substantial fraction of all predicted genes in the human and mouse genomes are generated.
Journal ArticleDOI

Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression

TL;DR: It is demonstrated that a family of miRNAs sharing sequence identity with miRNA-16 (miR-16) negatively regulates cellular growth and cell cycle progression and coordinately regulates targets that may act in concert to controlcell cycle progression.